Grenoble, 21 December 2005
A key that opens cells to the deadly malaria parasite
Researchers at the International Centre for Genetic Engineering and Biotechnology [ICGEB] in India and a unit of the European Molecular Biology Laboratory [EMBL] in France have made a key discovery about a molecule that helps the malaria parasite infect human cells.
Hinxton,
Tuesday 6 December 2005
Setting the standard for computer models of life
In the December 6 issue of Nature Biotechnology,
scientists from 14 different organizations around
the world, including the EMBL-European Bioinformatics
Institute, propose a new quality standard for biochemical
models.
Hinxton,
Friday 2 December 2005
What to sequence next: Pick one species at a time
After humans, mice, chickens and others what genomes
should scientists sequence next?
Heidelberg,
Thursday 24 November 2005
The earliest animals had human-like genes
Species evolve at very different rates, and the
evolutionary line that produced humans seems to
be among the slowest.
Hamburg,
Wednesday 16 November 2005
New high-throughput crystallization facility at EMBL Hamburg to give boost to structural biology community
Today the European Molecular Biology Laboratory [EMBL] opens a new highthroughput crystallization facility at its Outstation located on the campus of the German Synchrotron Radiation Facility [DESY] in Hamburg, Germany.
Heidelberg,
Tuesday 15 November 2005
Many needles, many haystacks
Most of what happens in cells is the work
of machines
that contain dozens of molecules, chiefly
proteins. Most of what happens in cells is the work of machines that contain dozens of molecules, chiefly proteins. With the completion of human and other genomes, researchers now have a nearly complete 'parts list' of such machines; what's lacking is the manual telling where all the pieces go. A new study by scientists at the European Molecular Biology Laboratory [EMBL] promises to answer this question for some of the smallest and trickiest components in the cellular toolbox.
Monterotondo,
Heidelberg, Ulm, Sunday 13 November 2005
Limiting the damage in stroke
Scientists at the Universities of Heidelberg and Ulm and a unit of the European
Molecular Biology Laboratory [EMBL] in Monterotondo,
Italy, have discovered that a specific signal
within brain cells may determine whether they
live or die after a stroke.
Hinxton,
Monday 31 October 2005
ENFIN! Computational systems biology comes to a lab bench near you The Commission of the European Union has awarded
EUR 9 million over five years for a new Network
of Excellence that will make computational systems
biology accessible to bench scientists throughout
Europe and beyond.
Heidelberg,
Thursday 6 October 2005
Defusing dangerous mutations Mutations in genes are the basis of evolution, so we owe our existence to them. Most mutations are harmful, however, because they cause cells to build defective proteins. So cells have evolved quality control mechanisms that recognize and counteract genetic mistakes. Now scientists of the Molecular Medicine Partnership Unit [MMPU], a laboratory operated jointly by the European Molecular Biology Laboratory [EMBL] and the University of Heidelberg, have discovered new features of a key quality-control mechanism in our cells. These insights into Nonsense-Mediated Decay [NMD], a process by which cells destroy potentially harmful molecules, promise to clarify our understanding of how some mutations lead to disease.
Hinxton,
Monday 12 September 2005
European Commission funds EBI to do new research on synergies between bioinformatics and medical informatics The European Commission has selected the EBI to coordinate a project that will stimulate and explore synergies between bioinformatics [the science of storing, retrieving and analysing large amounts of biological information] and medical informatics [the science of processing, sharing and using large amounts of medical information].
Heidelberg,
Sunday 4 September 2005
A new link between stem cells and tumors Scientists at the European Molecular Biology Laboratory [EMBL] in Heidelberg and the Institute of Biomedical Research of the Parc Cient’fic de Barcelona [IRB-PCB] have now added key evidence to claims that some types of cancer originate with defects in stem cells.
Heidelberg, Thursday 25 August 2005
A double punch for female survival
Achieving equality between the sexes can be a challenge
even for single cells. Since evolution began removing
bits of male DNA to create the 'Y' chromosome, males
have had a single copy of certain key genes on the
X chromosome, whereas females have two. Normally
this would lead females to produce twice the amount
of some proteins, which could be fatal, but cells
have developed ways to prevent this.
Hinxton, Monday
22 August 2005
Public collections of DNA and RNA sequence reach 100 gigabases
The world's three leading public repositories for DNA and RNA sequence information have reached 100 gigabases [100,000,000,000 bases; the 'letters' of the genetic code] of sequence. Thanks to their data exchange policy, which has paved the way for the global exchange of many types of biological information, the three members of the International Nucleotide Sequence Database Collaboration [INSDC, www.insdc.org] – EMBL Bank [Hinxton, UK], GenBank [Bethesda, USA] and the DNA Data Bank of Japan [Mishima, Japan] all reached this milestone together.
Heidelberg,
Monday 18 July 2005
Molecular Medicine Partnership Unit initiates second phase
The first rate research from the Molecular Medicine
Partnership Unit [MMPU] is now set to continue for
the long-term. The European Molecular Biology Laboratory
[EMBL] and the Medical Faculty of University of
Heidelberg, who formed the joint venture in 2002,
have announced their plans to initiate a second
phase of the MMPU. The Unit has always combined
the strengths of medical science with that of molecular
biology. In this second phase, the links between
the institutions will be strengthened. There will
be an increased focus on recruiting additional research
groups from each organisation as well as intensifying
activities in post-graduate training.
Heidelberg,
Wednesday 13 July 2005
Actin moves chromosomes: fundamental thinking
Microtubules need a helping hand to find chromosomes
in dividing egg cells, scientists have discovered.
Although it was generally accepted that microtubules
act alone as the cellular ropes to pull chromosomes
into place, a new study by researchers at the European
Molecular Biology Laboratory [EMBL] shows that this
is not the case. They found that in large cells
such as animal eggs, something else is needed to
move the chromosomes into the correct location –
fibres of the cytoskeletal molecule actin.
Heidelberg, Tuesday 12 July 2005
Hunt for human genes involved in cell division under way
A systematic search through human genes has begun
at the European Molecular Biology Laboratory [EMBL]
in Heidelberg, Germany. Working within the MitoCheck
consortium that includes 10 other institutes throughout
Europe, the EMBL scientists will silence all human
genes, one-by-one, to find those involved in cell
division [mitosis] and to answer fundamental questions
of how cell division is regulated.
Hinxton,
Friday 1 July 2005 Trees, vines and nets: microbial evolution changes its face
EBI researchers have changed our view of 4
billion years of microbial evolution. Christos
Ouzounis and colleagues have gained intriguing
quantitative insights into how gene families
are transferred, not only 'vertically' through
passage from one organism to its progeny,
but also 'horizontally' through the exchange
of genetic material between distantly related
organisms.
Heidelberg,
Sunday 19 June 2005
A link between our body's energy levels and a protein that wraps our DNA?
Living organisms need to sense the amount of energy
that is available to them and regulate the activity
of their genes accordingly. Scientists have made
the unexpected finding that a histone protein, which
wraps DNA into tight bundles and regulates gene
activity, can bind a small molecule produced in
our cells. This novel finding in itself was a breakthrough
for researchers at the European Molecular Biology
Laboratory [EMBL], but what made it more interesting
was which specific molecule it binds – one from
a pathway known to be linked to obesity and aging.
Hinxton,
13 May 2005
EMBL-EBI expansion goes ahead with help from
The Wellcome Trust and UK Research Councils
The European Bioinformatics Institute [EMBL-EBI]
has received a big boost from The Wellcome Trust,
the Medical Research Council [MRC] and the Biotechnology
and Biological Sciences Research Council [BBSRC],
who have given funds to expand the EBI site in Hinxton,
Cambridgeshire, UK.
Heidelberg,
1 May 2005
EMBL's fourth Director-General, Dr Iain Mattaj, takes office Dr. Iain Mattaj today took over the leadership of
the European Molecular Biology Laboratory [EMBL],
a prominent basic research and training institute
with laboratories in France, Germany, Italy and
the UK.
Heidelberg, 21
April 2005
Whale bones and farm soil: Sequencing biodiversity
Instead of sequencing the
genome of one organism, why not sequence a drop of sea
water, a gram of farm soil or even a sunken whale
skeleton? Scientists at the European Molecular Biology
Laboratory [EMBL] in Heidelberg and their US
collaborators have done just that, and the result is a new
appreciation for the rich diversity of life that exists in the
most unlikely places.
Hinxton,
Pasadena, 11 April 2005
A new way to share models of biological systems
Today sees the
launch of BioModels, the world's first database of annotated
biological models. BioModels is the result of a collaboration
led by the European Bioinformatics Institute [UK] and the
SBML Team, an international group that develops opensource
standards to describe biological systems. Other
contributors include the Keck Graduate Institute [USA], the
Systems Biology Institute [Japan] and Stellenbosch
University [South Africa].
Heidelberg, Jena,
31 March 2005
The transparent organism: EMBLEM and
Carl Zeiss give labs a unique look at life
A novel high-tech
microscope will be brought to the marketplace, giving
laboratories everywhere fascinating new insights into living
organisms. EMBLEM Technology Transfer GmbH
[EMBLEM], the commercial entity of the European
Molecular Biology Laboratory [EMBL], announced today
that it has signed a licensing deal with technological leader
Carl Zeiss to commercialize a new technology called SPIM
[Selective Plane Illumination Microscopy].
Hinxton,
28 February 2005
Double recognition of EBI scientists by the ISCB
The International Society for
Computational Biology has named two scientists from the
European Bioinformatics Institute as the winners of its
awards for 2005. Janet Thornton wins the Senior Scientist
Accomplishment Award while the Overton Prize goes to
Ewan Birney.
Heidelberg,
Copenhagen, 3 February 2005
Biology in four dimensions
Most things that happen in the cell are the work
of 'molecular machines' – complexes of proteins
that carry out important cellular functions. Until
now, scientists didn't have a clear idea of when
proteins form these machines – are these complexes
pre-fabricated or put together on the spot for each
specific job? Researchers at the European Molecular
Biology Laboratory [EMBL], working closely with
scientists from the Technical University of Denmark
[DTU], have now answered that question by drawing
together many types of data in a fascinating new
model. The work is published in this week's edition
of Science.
Hinxton, 1 February
2005
European
bioinformatics grid receives 8 million Euro
The Commission of the European Union has awarded
8.3 million Euro to a pan-European task force who
will improve access to biological information for
scientists throughout and beyond Europe. The EMBRACE
Network of Excellence, which encompasses computational
biologists from 17 institutes in 11 countries and
is coordinated by the European Bioinformatics Institute's
Associate Director Graham Cameron, will use these
funds to simplify and standardize the way in which
biological information is served to the researchers
who use it.
Monterotondo,
25 January 2005
How do cells travel through our bodies?
One of the most basic yet least understood processes in our bodies is how cells crawl along tissues. This behavior is essential to the formation of an embryo and other processes, but it must be tightly controlled. A disturbance can lead to the spread of cancer cells or diseases like Spina bifida and Lissencephaly, in which cells fail to reach their proper destinations. Scientists from the European Molecular Biology Laboratory [EMBL] in Monterotondo have now made a significant step forward in understanding cell motility. |